The androgen receptor is expressed in almost all prostate cancer cells and the progression of this disease is largely dependent on androgen/androgen receptor signaling, which means inhibiting the production of androgens or antagonizing the effects of androgen receptors in the body through endocrine therapy can achieve the purpose of treating prostate cancer [4]. This evidence concerns the gene AR and prostate carcinoma.